Skip to content

Rapid Symptom Reduction Following Intramuscular Ketamine in Refractory Obsessive–Compulsive Disorder: A Case Report

Maxwell Angel

Case Reports in Psychiatry 2026 DOI: 10.1155/crps/6450306 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Case study Case report Peer reviewed
Sample size 1
Population 27-year-old female patient with severe, treatment-refractory OCD and comorbid depressive symptoms
Intervention Ketamine
Topics Esketamine Ketamine
Key findings After a single intramuscular ketamine administration, the patient's handwashing duration decreased by approximately 97%, from 6-hour sessions to 5-10 minute sessions, sustained over 10 days. The authors suggest this highlights an acute change in compulsive behavior but note confounding by concurrent pharmacotherapy.

Abstract

Introduction: Obsessive-compulsive disorder (OCD) is a chronic psychiatric condition that frequently presents with comorbid depressive disorders. For patients exhibiting treatment-refractory OCD and concurrent depressive disorder(s), there is growing clinical interest in the noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist ketamine as a rapid-acting intervention. This case report describes a 27-year-old female patient with severe, treatment-refractory OCD and comorbid depressive symptoms, detailing her response to a single intramuscular (IM) ketamine administration. Case Presentation: The patient's primary compulsion was that of handwashing, which she would partake in for ~6 h per handwashing session at the time of the first ketamine administration. This occurred daily over a 3.5-month period, wherein a single day would consist of up to 18 total hours of handwashing. These extreme compulsions resulted in severe in-home isolation, precluding in-person psychotherapy and employment. Despite ongoing management by an independent telepsychiatrist, the patient reported no symptom relief from her prescribed regimen of fluoxetine (80 mg) and alprazolam (1 mg, four times daily)-a pharmacotherapeutic approach that may have been clinically suboptimal given the potential for high-dose benzodiazepines to exacerbate obsessive-compulsive symptoms. Given the severity of her condition, she subsequently pursued treatment at an unaffiliated outpatient ketamine clinic.

Conclusion: Following a single IM ketamine administration, the patient experienced an acute, ~97% reduction in handwashing duration (from 6 h sessions to 5-10 min sessions) sustained over a 10-day period. This observation highlights an acute change in the patient's primary compulsive behavior. However, concurrent pharmacotherapy may confound the results, and prospective controlled trials are required to fully evaluate the efficacy of this intervention.